Iwamuro Masaya, Matsueda Katsunori, Takahashi Takahide, Omote Sizuma, Tanaka Takehiro, Ennishi Daisuke, Otsuka Fumio, Yoshino Tadashi, Okada Hiroyuki
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama
Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka.
Ann Clin Lab Sci. 2020 May;50(3):348-353.
Flow cytometry has not been widely used in routine clinical practice for the diagnosis of gastrointestinal lymphoma; this is mainly because of the absence of an appropriate protocol. Here, we established a protocol for flow cytometric analysis of a single biopsy specimen from the gastrointestinal mucosa and investigated its sensitivity and specificity.
In this prospective study, we enrolled patients with previously diagnosed gastrointestinal lymphoma and patients with gastrointestinal lesions that were suspected to be lymphoma.
Overall, 15 patients with gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (N=8), duodenal follicular lymphoma (grade 1; N=5), and benign lymphoid hyperplasia (ileum, N=1, and rectum, N=1) were included in this study. Of these, lymphocytes were isolated from 14 patients (93.3%). There were 200,000-1,500,000 viable cells per patient. Biopsy specimens from 10 out of the 12 patients with lymphoma were positive for light chain restriction; the two patients with benign lymphoid hyperplasia showed negative results.
An adequate number of lymphocytes for flow cytometry could be isolated from a single specimen of endoscopic mucosal biopsy from 93.3% of the patients. Overall, the sensitivity of flow cytometric analysis of light chain expression for the diagnosis of B-cell lymphoma was 83.3%, and the specificity was 100%. Although further investigation is required as the sample size of the present study was small, our study suggests a potential option for diagnosing B-cell lymphoma in the gastrointestinal mucosa.
流式细胞术尚未广泛应用于胃肠道淋巴瘤诊断的常规临床实践;这主要是因为缺乏合适的方案。在此,我们建立了一种用于胃肠道黏膜单个活检标本流式细胞术分析的方案,并研究了其敏感性和特异性。
在这项前瞻性研究中,我们纳入了先前诊断为胃肠道淋巴瘤的患者以及疑似淋巴瘤的胃肠道病变患者。
总体而言,本研究纳入了15例患者,其中包括胃黏膜相关淋巴组织结外边缘区淋巴瘤(n = 8)、十二指肠滤泡性淋巴瘤(1级;n = 5)以及良性淋巴组织增生(回肠,n = 1,直肠,n = 1)。其中,14例患者(93.3%)成功分离出淋巴细胞。每位患者有200,000 - 1,500,000个活细胞。12例淋巴瘤患者中有10例的活检标本轻链限制呈阳性;2例良性淋巴组织增生患者结果为阴性。
93.3%的患者可从内镜黏膜活检的单个标本中分离出足够数量用于流式细胞术分析的淋巴细胞。总体而言,流式细胞术分析轻链表达诊断B细胞淋巴瘤的敏感性为83.3%,特异性为100%。尽管由于本研究样本量较小需要进一步研究,但我们的研究提示了一种诊断胃肠道黏膜B细胞淋巴瘤的潜在方法。